In a breakthrough with applicability across many flu strains, researchers find a potential small molecule that mimics antibodies to treat disease.

Investigational therapeutic candidate made with four antibodies tethered together shows promise against influenza A and B.

“It’s as if they link arms together to form a stronger complex…”

“We have a great team here at Scripps Research for rational design of vaccines.”

The new study shows exactly why egg-based manufacturing is a problem for the H3N2 influenza subtype.

A team of researchers from Scripps Research and Janssen Pharmaceuticals has devised artificial peptide molecules that neutralize a broad range of influenza virus strains.